Description
Latin name
Hepa-Merz
Release form
Concentrate for solution for infusion
Packing
10 ampoules of 10 ml.
Indications
acute and chronic liver disease, accompanied by hyperammonemia
hepatic encephalopathy (latent and severe), including as a part of complex therapy for impaired consciousness (precoma or coma)
parenteral nutrition of patients with protein deficiency (as a corrective supplement).
Contraindications
Severe renal failure (serum creatinine> 3 mg / 1 dl)
Lactation (breastfeeding)
Hypersensitivity to the drug.
Use during pregnancy and lactation
During pregnancy, the use of Hepa-Merz is possible only under the strict supervision of a physician. During treatment, breastfeeding should be discontinued
Ingredients
active substance: ornithine aspartate 5 g
excipients: water for injection
Dosage and administration
Intravenously, usually 20 g (4 ampoules), with hepatic encephalopathy, depending on the severity of the condition, up to 40 g (8 ampoules) per day, maximum infusion rate – 5 g .
Side effects
Rarely – skin reactions, in some cases – nausea, vomiting.
Overdose
Symptoms: increased severity of side effects.
Storage Conditions
At a temperature not exceeding 25 ° C.
Shelf life
5 years.
Deystvuyushtee substance
Ornithine
Terms and conditions
By prescription
dosage form
infusion solution
Possible product names
GEPA-MERZ 0.5 / ML 10ML N10 AMP KONTS D / R-RA D / INF
GEPA-MERZ 5.0 / 10ML N10 AMP
Hepa-Merz 500 mg / ml 10 ml No. 10 amp
Hepa-Merz ampoules 5 g, 10 ml, 10 pcs.
Hepa-Merz conc d / inf amp 5g 10ml N10 Germany
